{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T12:41:35Z","timestamp":1793882495834,"version":"4.7.0"},"reference-count":109,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.bcp.2025.117087","type":"journal-article","created":{"date-parts":[[2025,6,24]],"date-time":"2025-06-24T11:29:33Z","timestamp":1750764573000},"page":"117087","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"special_numbering":"C","title":["Regulatory T cells and their role in inflammatory bowel disease: molecular targets, therapeutic strategies and translational advances"],"prefix":"10.1016","volume":"239","author":[{"given":"Chaelin","family":"Lee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ye Won","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min Ho","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong Jun","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5272-712X","authenticated-orcid":false,"given":"Inmoo","family":"Rhee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bcp.2025.117087_b0005","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1146\/annurev-immunol-030409-101212","article-title":"Differentiation of effector CD4 T cell populations (*)","volume":"28","author":"Zhu","year":"2010","journal-title":"Annu. Rev. Immunol."},{"issue":"3","key":"10.1016\/j.bcp.2025.117087_b0010","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.4049\/jimmunol.155.3.1151","article-title":"Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases","volume":"155","author":"Sakaguchi","year":"1995","journal-title":"J. Immunol."},{"issue":"7","key":"10.1016\/j.bcp.2025.117087_b0015","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1038\/nri2343","article-title":"How regulatory T cells work","volume":"8","author":"Vignali","year":"2008","journal-title":"Nat. Rev. Immunol."},{"issue":"5","key":"10.1016\/j.bcp.2025.117087_b0020","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1016\/j.cell.2015.08.021","article-title":"A distinct function of regulatory T cells in tissue protection","volume":"162","author":"Arpaia","year":"2015","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.bcp.2025.117087_b0025","doi-asserted-by":"crossref","first-page":"3913","DOI":"10.1038\/s41467-021-24213-6","article-title":"Single-cell transcriptomic analysis reveals disparate effector differentiation pathways in human Treg compartment","volume":"12","author":"Luo","year":"2021","journal-title":"Nat. Commun."},{"issue":"2","key":"10.1016\/j.bcp.2025.117087_b0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.immuni.2019.01.001","article-title":"Single-cell transcriptomics of regulatory T cells reveals trajectories of tissue adaptation","volume":"50","author":"Miragaia","year":"2019","journal-title":"Immunity"},{"issue":"1","key":"10.1016\/j.bcp.2025.117087_b0035","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1111\/j.1600-065X.2011.01018.x","article-title":"Regulatory T cells and Foxp3","volume":"241","author":"Rudensky","year":"2011","journal-title":"Immunol. Rev."},{"issue":"5609","key":"10.1016\/j.bcp.2025.117087_b0040","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1126\/science.1079490","article-title":"Control of regulatory T cell development by the transcription factor Foxp3","volume":"299","author":"Hori","year":"2003","journal-title":"Science"},{"issue":"2","key":"10.1016\/j.bcp.2025.117087_b0045","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1038\/mi.2015.74","article-title":"Foxp3(+) T cells expressing RORgammat represent a stable regulatory T-cell effector lineage with enhanced suppressive capacity during intestinal inflammation","volume":"9","author":"Yang","year":"2016","journal-title":"Mucosal Immunol."},{"issue":"Supplement_2","key":"10.1016\/j.bcp.2025.117087_b0050","doi-asserted-by":"crossref","first-page":"S9","DOI":"10.1093\/jcag\/gwad004","article-title":"The 2023 impact of inflammatory bowel disease in Canada: epidemiology of IBD","volume":"6","author":"Coward","year":"2023","journal-title":"J. Can. Assoc. Gastroenterol."},{"issue":"5","key":"10.1016\/j.bcp.2025.117087_b0055","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.3390\/jcm9051273","article-title":"Revisiting inflammatory bowel disease: pathology, treatments, challenges and emerging therapeutics including drug leads from natural products","volume":"9","author":"Yeshi","year":"2020","journal-title":"J. Clin. Med."},{"issue":"7","key":"10.1016\/j.bcp.2025.117087_b0060","doi-asserted-by":"crossref","first-page":"1868","DOI":"10.1053\/j.gastro.2005.03.043","article-title":"Peripheral and intestinal regulatory CD4+ CD25high T cells in inflammatory bowel disease","volume":"128","author":"Maul","year":"2005","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bcp.2025.117087_b0065","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/8813558","article-title":"The function and role of the Th17\/Treg cell balance in inflammatory bowel disease","volume":"2020","author":"Yan","year":"2020","journal-title":"J. Immunol. Res."},{"issue":"2","key":"10.1016\/j.bcp.2025.117087_b0070","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.immuni.2019.01.020","article-title":"Human FOXP3(+) regulatory T cell heterogeneity and function in autoimmunity and cancer","volume":"50","author":"Wing","year":"2019","journal-title":"Immunity"},{"issue":"9","key":"10.1016\/j.bcp.2025.117087_b0075","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1038\/ni.3522","article-title":"Affinity for self antigen selects Treg cells with distinct functional properties","volume":"17","author":"Wyss","year":"2016","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.bcp.2025.117087_b0080","series-title":"Seminars in Immunology","article-title":"Peripheral education of the immune system by the colonic microbiota","author":"Kuhn","year":"2013"},{"issue":"2","key":"10.1016\/j.bcp.2025.117087_b0085","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.it.2012.11.002","article-title":"Differentiation and function of Foxp3(+) effector regulatory T cells","volume":"34","author":"Cretney","year":"2013","journal-title":"Trends Immunol."},{"issue":"7","key":"10.1016\/j.bcp.2025.117087_b0090","doi-asserted-by":"crossref","first-page":"3433","DOI":"10.4049\/jimmunol.0904028","article-title":"Expression of Helios, an Ikaros transcription factor family member, differentiates thymic-derived from peripherally induced Foxp3+ T regulatory cells","volume":"184","author":"Thornton","year":"2010","journal-title":"J. Immunol."},{"issue":"6","key":"10.1016\/j.bcp.2025.117087_b0095","doi-asserted-by":"crossref","DOI":"10.1002\/eji.202350619","article-title":"High sensitivity of host Helios(+)\/Neuropilin-1(+) Treg to pretransplant conditioning hampers development of OX40(bright)\/integrin-beta7(+) regulatory cells in acute gastrointestinal GvHD","volume":"54","author":"Lupsa","year":"2024","journal-title":"Eur. J. Immunol."},{"issue":"7282","key":"10.1016\/j.bcp.2025.117087_b0100","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1038\/nature08750","article-title":"Role of conserved non-coding DNA elements in the Foxp3 gene in regulatory T-cell fate","volume":"463","author":"Zheng","year":"2010","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.bcp.2025.117087_b0105","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1038\/ni.3646","article-title":"Guidance of regulatory T cell development by Satb1-dependent super-enhancer establishment","volume":"18","author":"Kitagawa","year":"2017","journal-title":"Nat. Immunol."},{"issue":"6","key":"10.1016\/j.bcp.2025.117087_b0110","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1038\/s41422-020-0324-7","article-title":"Transcriptional and epigenetic basis of Treg cell development and function: its genetic anomalies or variations in autoimmune diseases","volume":"30","author":"Ohkura","year":"2020","journal-title":"Cell Res."},{"issue":"11","key":"10.1016\/j.bcp.2025.117087_b0115","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.it.2013.08.003","article-title":"Transcriptional control of regulatory T cell development and function","volume":"34","author":"Luo","year":"2013","journal-title":"Trends Immunol."},{"issue":"1","key":"10.1016\/j.bcp.2025.117087_b0120","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.immuni.2008.12.009","article-title":"Global mapping of H3K4me3 and H3K27me3 reveals specificity and plasticity in lineage fate determination of differentiating CD4+ T cells","volume":"30","author":"Wei","year":"2009","journal-title":"Immunity"},{"issue":"3","key":"10.1016\/j.bcp.2025.117087_b0125","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.immuni.2012.05.031","article-title":"T-bet+ Treg cells undergo abortive Th1 cell differentiation due to impaired expression of IL-12 receptor \u03b22","volume":"37","author":"Koch","year":"2012","journal-title":"Immunity"},{"issue":"3","key":"10.1016\/j.bcp.2025.117087_b0130","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/j.immuni.2012.06.014","article-title":"The cytokines interleukin 27 and interferon-\u03b3 promote distinct Treg cell populations required to limit infection-induced pathology","volume":"37","author":"Hall","year":"2012","journal-title":"Immunity"},{"issue":"1","key":"10.1016\/j.bcp.2025.117087_b0135","doi-asserted-by":"crossref","first-page":"5341","DOI":"10.1038\/s41467-020-18925-4","article-title":"Early-onset autoimmunity associated with SOCS1 haploinsufficiency","volume":"11","author":"Hadjadj","year":"2020","journal-title":"Nat. Commun."},{"issue":"3","key":"10.1016\/j.bcp.2025.117087_b0140","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.immuni.2011.08.012","article-title":"An essential role of the transcription factor GATA-3 for the function of regulatory T cells","volume":"35","author":"Wang","year":"2011","journal-title":"Immunity"},{"issue":"11","key":"10.1016\/j.bcp.2025.117087_b0145","doi-asserted-by":"crossref","first-page":"4503","DOI":"10.1172\/JCI57456","article-title":"GATA3 controls Foxp3+ regulatory T cell fate during inflammation in mice","volume":"121","author":"Wohlfert","year":"2011","journal-title":"J. Clin. Invest."},{"issue":"3","key":"10.1016\/j.bcp.2025.117087_b0150","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/j.immuni.2015.02.004","article-title":"Regulatory T cell reprogramming toward a Th2-cell-like lineage impairs oral tolerance and promotes food allergy","volume":"42","author":"Rivas","year":"2015","journal-title":"Immunity"},{"issue":"3","key":"10.1016\/j.bcp.2025.117087_b0155","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/j.celrep.2017.06.079","article-title":"An atlas of human regulatory T helper-like cells reveals features of Th2-like Tregs that support a tumorigenic environment","volume":"20","author":"Halim","year":"2017","journal-title":"Cell Rep."},{"issue":"6","key":"10.1016\/j.bcp.2025.117087_b0160","doi-asserted-by":"crossref","first-page":"3137","DOI":"10.1172\/JCI130426","article-title":"IRF4 instructs effector Treg differentiation and immune suppression in human cancer","volume":"130","author":"Alvisi","year":"2020","journal-title":"J. Clin. Invest."},{"issue":"6","key":"10.1016\/j.bcp.2025.117087_b0165","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1084\/jem.20161104","article-title":"Interleukin 4 promotes the development of ex-Foxp3 Th2 cells during immunity to intestinal helminths","volume":"214","author":"Pelly","year":"2017","journal-title":"J. Exp. Med."},{"issue":"1","key":"10.1016\/j.bcp.2025.117087_b0170","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.immuni.2008.05.007","article-title":"Molecular antagonism and plasticity of regulatory and inflammatory T cell programs","volume":"29","author":"Yang","year":"2008","journal-title":"Immunity"},{"issue":"6","key":"10.1016\/j.bcp.2025.117087_b0175","first-page":"2340","article-title":"Human CD25highFoxp3pos regulatory T cells differentiate into IL-17\u2013producing cells","volume":"112","author":"Koenen","year":"2008","journal-title":"Blood J. Am. Soc. Hematol."},{"issue":"6","key":"10.1016\/j.bcp.2025.117087_b0180","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1016\/j.cell.2006.07.035","article-title":"The orphan nuclear receptor ROR\u03b3t directs the differentiation program of proinflammatory IL-17+ T helper cells","volume":"126","author":"Ivanov","year":"2006","journal-title":"Cell"},{"issue":"6","key":"10.1016\/j.bcp.2025.117087_b0185","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/j.immuni.2006.06.002","article-title":"Th17: an effector CD4 T cell lineage with regulatory T cell ties","volume":"24","author":"Weaver","year":"2006","journal-title":"Immunity"},{"issue":"6251","key":"10.1016\/j.bcp.2025.117087_b0190","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1126\/science.aac4263","article-title":"The microbiota regulates type 2 immunity through ROR\u03b3t+ T cells","volume":"349","author":"Ohnmacht","year":"2015","journal-title":"Science"},{"issue":"2","key":"10.1016\/j.bcp.2025.117087_b0195","doi-asserted-by":"crossref","DOI":"10.1002\/eji.202250007","article-title":"Regulatory T cells as a therapeutic approach for inflammatory bowel disease","volume":"53","author":"Laukova","year":"2023","journal-title":"Eur. J. Immunol."},{"issue":"1","key":"10.1016\/j.bcp.2025.117087_b0200","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1038\/ni.1818","article-title":"Regulatory T cells exert checks and balances on self tolerance and autoimmunity","volume":"11","author":"Wing","year":"2010","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.bcp.2025.117087_b0205","doi-asserted-by":"crossref","first-page":"3100","DOI":"10.3389\/fimmu.2019.03100","article-title":"Treg Heterogeneity, Function, and Homeostasis","volume":"10","author":"Shevyrev","year":"2019","journal-title":"Front. Immunol."},{"issue":"7581","key":"10.1016\/j.bcp.2025.117087_b0210","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1038\/nature16169","article-title":"Immune homeostasis enforced by co-localized effector and regulatory T cells","volume":"528","author":"Liu","year":"2015","journal-title":"Nature"},{"issue":"7090","key":"10.1016\/j.bcp.2025.117087_b0215","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1038\/nature04753","article-title":"Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells","volume":"441","author":"Bettelli","year":"2006","journal-title":"Nature"},{"issue":"12","key":"10.1016\/j.bcp.2025.117087_b0220","doi-asserted-by":"crossref","first-page":"2108","DOI":"10.1038\/s41590-023-01667-y","article-title":"Selective IL-27 production by intestinal regulatory T cells permits gut-specific regulation of T(H)17 cell immunity","volume":"24","author":"Lin","year":"2023","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.bcp.2025.117087_b0225","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.716499","article-title":"Intestinal Regulatory T Cells as Specialized Tissue-Restricted Immune Cells in Intestinal Immune Homeostasis and Disease","volume":"12","author":"Jacobse","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bcp.2025.117087_b0230","article-title":"Tissue resident Foxp3(+) regulatory T cells: sentinels and saboteurs in health and disease","volume":"13","author":"Lee","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bcp.2025.117087_b0235","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2024.107184","article-title":"Metabolic regulation of the Th17\/Treg balance in inflammatory bowel disease","volume":"203","author":"Zhang","year":"2024","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.bcp.2025.117087_b0240","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.cytogfr.2022.07.005","article-title":"The involvement of TH17 cells in the pathogenesis of IBD","volume":"69","author":"Jiang","year":"2023","journal-title":"Cytokine Growth Factor Rev."},{"issue":"1","key":"10.1016\/j.bcp.2025.117087_b0245","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/imm.13280","article-title":"Cytokine-regulated Th17 plasticity in human health and diseases","volume":"163","author":"Cerboni","year":"2021","journal-title":"Immunology"},{"issue":"7422","key":"10.1016\/j.bcp.2025.117087_b0250","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1038\/nature11582","article-title":"Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease","volume":"491","author":"Jostins","year":"2012","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.bcp.2025.117087_b0255","doi-asserted-by":"crossref","first-page":"2427","DOI":"10.1038\/s41467-018-04365-8","article-title":"IBD risk loci are enriched in multigenic regulatory modules encompassing putative causative genes","volume":"9","author":"Momozawa","year":"2018","journal-title":"Nat. Commun."},{"issue":"7351","key":"10.1016\/j.bcp.2025.117087_b0260","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1038\/nature10209","article-title":"Genetics and pathogenesis of inflammatory bowel disease","volume":"474","author":"Khor","year":"2011","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.bcp.2025.117087_b0265","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.4049\/jimmunol.1000082","article-title":"Genome-wide identification of human FOXP3 target genes in natural regulatory T cells","volume":"185","author":"Sadlon","year":"2010","journal-title":"J. Immunol."},{"key":"10.1016\/j.bcp.2025.117087_b0270","article-title":"Single-cell omics in inflammatory bowel disease: recent insights and future clinical applications","author":"Gudino","year":"2025","journal-title":"Gut"},{"issue":"9","key":"10.1016\/j.bcp.2025.117087_b0275","doi-asserted-by":"crossref","first-page":"1926","DOI":"10.1093\/ibd\/izy182","article-title":"Faecalibacterium prausnitzii produces butyrate to maintain Th17\/Treg balance and to ameliorate colorectal colitis by inhibiting histone deacetylase 1","volume":"24","author":"Zhou","year":"2018","journal-title":"Inflamm. Bowel Dis."},{"issue":"4","key":"10.1016\/j.bcp.2025.117087_b0280","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1038\/ng.553","article-title":"Genome-wide association study for ulcerative colitis identifies risk loci at 7q22 and 22q13 (IL17REL)","volume":"42","author":"Franke","year":"2010","journal-title":"Nat. Genet."},{"key":"10.1016\/j.bcp.2025.117087_b0285","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.jaut.2015.01.001","article-title":"Low-dose interleukin-2 fosters a dose-dependent regulatory T cell tuned milieu in T1D patients","volume":"58","author":"Rosenzwajg","year":"2015","journal-title":"J. Autoimmun."},{"issue":"5835","key":"10.1016\/j.bcp.2025.117087_b0290","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1126\/science.1145697","article-title":"Reciprocal TH17 and regulatory T cell differentiation mediated by retinoic acid","volume":"317","author":"Mucida","year":"2007","journal-title":"Science"},{"issue":"7459","key":"10.1016\/j.bcp.2025.117087_b0295","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1038\/nature12297","article-title":"mTORC1 couples immune signals and metabolic programming to establish T(reg)-cell function","volume":"499","author":"Zeng","year":"2013","journal-title":"Nature"},{"issue":"8","key":"10.1016\/j.bcp.2025.117087_b0300","doi-asserted-by":"crossref","DOI":"10.15252\/embj.2021109803","article-title":"Batf stabilizes Th17 cell development via impaired Stat5 recruitment of Ets1-Runx1 complexes","volume":"42","author":"Pham","year":"2023","journal-title":"EMBO J."},{"issue":"7","key":"10.1016\/j.bcp.2025.117087_b0305","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0199631","article-title":"Genistein induces macrophage polarization and systemic cytokine to ameliorate experimental colitis","volume":"13","author":"Abron","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.bcp.2025.117087_b0310","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.molimm.2023.11.013","article-title":"alpha-mangostin derivatives ameliorated mouse DSS-induced chronic colitis via regulating Th17\/Treg balance","volume":"166","author":"Yang","year":"2024","journal-title":"Mol. Immunol."},{"issue":"8","key":"10.1016\/j.bcp.2025.117087_b0315","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1111\/1440-1681.13654","article-title":"Trifolirhizin regulates the balance of Th17\/Treg cells and inflammation in the ulcerative colitis mice through inhibiting the TXNIP-mediated activation of NLRP3 inflammasome","volume":"49","author":"Zhang","year":"2022","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"issue":"10","key":"10.1016\/j.bcp.2025.117087_b0320","doi-asserted-by":"crossref","DOI":"10.1096\/fj.202301127RR","article-title":"Complanatuside A ameliorates 2,4,6-trinitrobenzene sulfonic acid-induced colitis in mice by regulating the Th17\/Treg balance via the JAK2\/STAT3 signaling pathway","volume":"38","author":"Wang","year":"2024","journal-title":"FASEB J."},{"issue":"9","key":"10.1016\/j.bcp.2025.117087_b0325","article-title":"Metformin ameliorates inflammatory bowel disease by suppression of the STAT3 signaling pathway and regulation of the between Th17\/Treg balance","volume":"10","author":"Lee","year":"2015","journal-title":"PLoS One"},{"issue":"14","key":"10.1016\/j.bcp.2025.117087_b0330","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1056\/NEJMoa2033617","article-title":"Ozanimod as induction and maintenance therapy for ulcerative colitis","volume":"385","author":"Sandborn","year":"2021","journal-title":"N. Engl. J. Med."},{"issue":"7","key":"10.1016\/j.bcp.2025.117087_b0335","doi-asserted-by":"crossref","first-page":"4234","DOI":"10.4049\/jimmunol.1003668","article-title":"Modulation of innate and adaptive immune responses by tofacitinib (CP-690,550)","volume":"186","author":"Ghoreschi","year":"2011","journal-title":"J. Immunol."},{"key":"10.1016\/j.bcp.2025.117087_b0340","article-title":"Infliximab in inflammatory bowel disease","volume":"10","author":"Papamichael","year":"2019","journal-title":"Therapeut. Adv. Chronic Dis."},{"issue":"7","key":"10.1016\/j.bcp.2025.117087_b0345","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.1053\/j.gastro.2005.03.003","article-title":"Infliximab as rescue therapy in severe to moderately severe ulcerative colitis: a randomized, placebo-controlled study","volume":"128","author":"J\u00e4rnerot","year":"2005","journal-title":"Gastroenterology"},{"issue":"9","key":"10.1016\/j.bcp.2025.117087_b0350","first-page":"1172","article-title":"Co-administration of 1, 25-dihydroxyvitamin D3 and infliximab improves colitis in mice by modulating Treg differentiation, Iran","volume":"27","author":"Hu","year":"2024","journal-title":"J. Basic Med. Sci."},{"issue":"9","key":"10.1016\/j.bcp.2025.117087_b0355","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1016\/j.dld.2021.11.014","article-title":"Vedolizumab as the first line of biologic therapy for ulcerative colitis and Crohn's disease\u2013a systematic review with meta-analysis","volume":"54","author":"Attauabi","year":"2022","journal-title":"Dig. Liver Dis."},{"issue":"Supplement_2","key":"10.1016\/j.bcp.2025.117087_b0360","doi-asserted-by":"crossref","DOI":"10.1093\/ecco-jcc\/jjac034","article-title":"Interleukin-23 in the Pathogenesis of Inflammatory Bowel Disease and Implications for Therapeutic intervention","volume":"16","author":"Sewell","year":"2022","journal-title":"J. Crohns Colitis"},{"key":"10.1016\/j.bcp.2025.117087_b0365","doi-asserted-by":"crossref","unstructured":"Lukasik, Z., et al., Crossing the boundaries: IL-23 and its role in linking inflammation of the skin, gut and joints. Rheumatology (Oxford), 2021. 60(Suppl 4): p. iv16-iv27.10.1093\/rheumatology\/keab385.","DOI":"10.1093\/rheumatology\/keab385"},{"issue":"5","key":"10.1016\/j.bcp.2025.117087_b0370","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/S1074-7613(00)00070-4","article-title":"Novel p19 protein engages IL-12p40 to form a cytokine, IL-23, with biological activities similar as well as distinct from IL-12","volume":"13","author":"Oppmann","year":"2000","journal-title":"Immunity"},{"key":"10.1016\/j.bcp.2025.117087_b0375","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.982238","article-title":"The regulatory mechanism and potential application of IL-23 in autoimmune diseases","volume":"13","author":"Xiong","year":"2022","journal-title":"Front. Pharmacol."},{"issue":"2","key":"10.1016\/j.bcp.2025.117087_b0380","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.immuni.2010.08.010","article-title":"Interleukin-23 drives intestinal inflammation through direct activity on T cells","volume":"33","author":"Ahern","year":"2010","journal-title":"Immunity"},{"issue":"4","key":"10.1016\/j.bcp.2025.117087_b0385","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1189\/jlb.0810456","article-title":"The increased expression of IL-23 in inflammatory bowel disease promotes intraepithelial and lamina propria lymphocyte inflammatory responses and cytotoxicity","volume":"89","author":"Liu","year":"2011","journal-title":"J. Leukoc. Biol."},{"issue":"5","key":"10.1016\/j.bcp.2025.117087_b0390","doi-asserted-by":"crossref","DOI":"10.3390\/jcm13051519","article-title":"Ustekinumab in the treatment of inflammatory bowel diseases: evolving paradigms","volume":"13","author":"Mocci","year":"2024","journal-title":"J. Clin. Med."},{"issue":"26","key":"10.1016\/j.bcp.2025.117087_b0395","doi-asserted-by":"crossref","first-page":"2444","DOI":"10.1056\/NEJMoa2207940","article-title":"Mirikizumab as induction and maintenance therapy for ulcerative colitis","volume":"388","author":"D\u2019Haens","year":"2023","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bcp.2025.117087_b0400","doi-asserted-by":"crossref","DOI":"10.1016\/S0140-6736(24)01762-8","article-title":"Efficacy and safety of mirikizumab in patients with moderately-to-severely active Crohn's disease: a phase 3, multicentre, randomised, double-blind, placebo-controlled and active-controlled, treat-through study","author":"Ferrante","year":"2024","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.bcp.2025.117087_b0405","doi-asserted-by":"crossref","first-page":"e96","DOI":"10.1097\/SAP.0000000000001947","article-title":"Cell-based therapies for chronic wounds tested in clinical studies","volume":"83","author":"Domaszewska-Szostek","year":"2019","journal-title":"Ann. Plast. Surg."},{"issue":"12","key":"10.1016\/j.bcp.2025.117087_b0410","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1136\/gut.2010.215152","article-title":"Autologous bone marrow-derived mesenchymal stromal cell treatment for refractory luminal Crohn's disease: results of a phase I study","volume":"59","author":"Duijvestein","year":"2010","journal-title":"Gut"},{"key":"10.1016\/j.bcp.2025.117087_b0415","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/scrt216","article-title":"Mesenchymal stem cells generate a CD4+ CD25+ Foxp3+ regulatory T cell population during the differentiation process of Th1 and Th17 cells","volume":"4","author":"Luz-Crawford","year":"2013","journal-title":"Stem Cell Res Ther"},{"issue":"1","key":"10.1016\/j.bcp.2025.117087_b0420","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1186\/s13287-024-03809-x","article-title":"Mesenteric lymph nodes: a critical site for the up-regulatory effect of hUC-MSCs on Treg cells by producing TGF-\u03b21 in colitis treatment","volume":"15","author":"Zhang","year":"2024","journal-title":"Stem Cell Res Ther"},{"issue":"3","key":"10.1016\/j.bcp.2025.117087_b0425","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1167\/iovs.04-0495","article-title":"Immunosuppressive factors secreted by human amniotic epithelial cells","volume":"46","author":"Li","year":"2005","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.bcp.2025.117087_b0430","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1007\/s11481-020-09969-w","article-title":"Human amniotic epithelial cells alleviate a mouse model of Parkinson\u2019s disease mainly by neuroprotective, anti-oxidative and anti-inflammatory factors","volume":"16","author":"Zhang","year":"2021","journal-title":"J. Neuroimmune Pharmacol."},{"issue":"3","key":"10.1016\/j.bcp.2025.117087_b0435","doi-asserted-by":"crossref","first-page":"241","DOI":"10.15283\/ijsc21032","article-title":"Therapeutic aspects of mesenchymal stem cell-based cell therapy with a focus on human amniotic epithelial cells in multiple sclerosis: a mechanistic review","volume":"14","author":"ArefNezhad","year":"2021","journal-title":"Int. J. Stem Cells"},{"key":"10.1016\/j.bcp.2025.117087_b0440","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2023.110265","article-title":"Cytokine-stimulated human amniotic epithelial cells alleviate DSS-induced colitis in mice through anti-inflammation and regulating Th17\/Treg balance","volume":"120","author":"Wang","year":"2023","journal-title":"Int. Immunopharmacol."},{"issue":"5","key":"10.1016\/j.bcp.2025.117087_b0445","doi-asserted-by":"crossref","DOI":"10.1053\/j.gastro.2012.07.116","article-title":"Safety and efficacy of antigen-specific regulatory T-cell therapy for patients with refractory Crohn's disease","volume":"143","author":"Desreumaux","year":"2012","journal-title":"Gastroenterology"},{"issue":"3","key":"10.1016\/j.bcp.2025.117087_b0450","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1038\/cmi.2014.56","article-title":"A B-1a cell subset induces Foxp3\u2212 T cells with regulatory activity through an IL-10-independent pathway","volume":"12","author":"Hsu","year":"2015","journal-title":"Cell. Mol. Immunol."},{"issue":"1","key":"10.1016\/j.bcp.2025.117087_b0455","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1007\/s00018-024-05378-x","article-title":"Characterization of novel CD8+ regulatory T cells and their modulatory effects in murine model of inflammatory bowel disease","volume":"81","author":"Fan","year":"2024","journal-title":"Cell. Mol. Life Sci."},{"issue":"1","key":"10.1016\/j.bcp.2025.117087_b0460","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1186\/s13046-022-02327-z","article-title":"CAR race to cancer immunotherapy: from CAR T, CAR NK to CAR macrophage therapy","volume":"41","author":"Pan","year":"2022","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"8","key":"10.1016\/j.bcp.2025.117087_b0465","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1056\/NEJMoa2024850","article-title":"Idecabtagene vicleucel in relapsed and refractory multiple myeloma","volume":"384","author":"Munshi","year":"2021","journal-title":"N. Engl. J. Med."},{"issue":"11","key":"10.1016\/j.bcp.2025.117087_b0470","doi-asserted-by":"crossref","DOI":"10.1016\/j.ccell.2023.09.010","article-title":"Cooperative CAR targeting to selectively eliminate AML and minimize escape","volume":"41","author":"Haubner","year":"2023","journal-title":"Cancer Cell"},{"issue":"11","key":"10.1016\/j.bcp.2025.117087_b0475","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1038\/s41587-023-01686-y","article-title":"Single-cell mapping of combinatorial target antigens for CAR switches using logic gates","volume":"41","author":"Kwon","year":"2023","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.bcp.2025.117087_b0480","series-title":"CAAR NK and T cells to eliminate autoreactive lymphocytes in autoimmune disorders","author":"Seifert","year":"2024"},{"issue":"3","key":"10.1016\/j.bcp.2025.117087_b0485","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1038\/s41434-022-00358-x","article-title":"Preclinical assessment of antigen-specific chimeric antigen receptor regulatory T cells for use in solid organ transplantation","volume":"30","author":"Proics","year":"2023","journal-title":"Gene Ther."},{"issue":"5804","key":"10.1016\/j.bcp.2025.117087_b0490","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1126\/science.1135245","article-title":"A genome-wide association study identifies IL23R as an inflammatory bowel disease gene","volume":"314","author":"Duerr","year":"2006","journal-title":"Science"},{"key":"10.1016\/j.bcp.2025.117087_b0495","article-title":"IL23R-specific CAR tregs for the treatment of Crohn\u2019s disease","author":"Cui","year":"2024","journal-title":"J. Crohn's Colitis"},{"issue":"38","key":"10.1016\/j.bcp.2025.117087_b0500","doi-asserted-by":"crossref","first-page":"13610","DOI":"10.1073\/pnas.0502174102","article-title":"Pathophysiological role of Toll-like receptor 5 engagement by bacterial flagellin in colonic inflammation","volume":"102","author":"Rhee","year":"2005","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.bcp.2025.117087_b0505","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaut.2022.102961","article-title":"Flagellin-specific human CAR Tregs for immune regulation in IBD","volume":"134","author":"Boardman","year":"2023","journal-title":"J. Autoimmun."},{"issue":"2","key":"10.1016\/j.bcp.2025.117087_b0510","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.jcmgh.2019.05.001","article-title":"Low-Dose Interleukin-2 Ameliorates Colitis in a Preclinical Humanized Mouse Model","volume":"8","author":"Goettel","year":"2019","journal-title":"Cell. Mol. Gastroenterol. Hepatol."},{"issue":"5","key":"10.1016\/j.bcp.2025.117087_b0515","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1016\/j.jhep.2013.12.027","article-title":"Reduced FOXP3(+) regulatory T cells in patients with primary sclerosing cholangitis are associated with IL2RA gene polymorphisms","volume":"60","author":"Sebode","year":"2014","journal-title":"J. Hepatol."},{"issue":"11","key":"10.1016\/j.bcp.2025.117087_b0520","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2021.110124","article-title":"Control of Foxp3 induction and maintenance by sequential histone acetylation and DNA demethylation","volume":"37","author":"Li","year":"2021","journal-title":"Cell Rep."},{"issue":"6","key":"10.1016\/j.bcp.2025.117087_b0525","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/j.jpha.2023.05.009","article-title":"Small molecule inhibitors of RORgammat for Th17 regulation in inflammatory and autoimmune diseases","volume":"13","author":"Zeng","year":"2023","journal-title":"J. Pharm. Anal."},{"issue":"2","key":"10.1016\/j.bcp.2025.117087_b0530","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.immuni.2024.01.010","article-title":"LAG-3, TIM-3, and TIGIT: Distinct functions in immune regulation","volume":"57","author":"Joller","year":"2024","journal-title":"Immunity"},{"issue":"2","key":"10.1016\/j.bcp.2025.117087_b0535","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.ajt.2022.12.011","article-title":"TIGIT agonism alleviates costimulation blockade-resistant rejection in a regulatory T cell-dependent manner","volume":"23","author":"Hartigan","year":"2023","journal-title":"Am. J. Transplant."},{"key":"10.1016\/j.bcp.2025.117087_b0540","doi-asserted-by":"crossref","DOI":"10.1016\/j.coi.2024.102511","article-title":"Navigating the metabolic landscape of regulatory T cells: from autoimmune diseases to tumor microenvironments","volume":"92","author":"Harm","year":"2025","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.bcp.2025.117087_b0545","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellimm.2021.104378","article-title":"Rapamycin facilitates differentiation of regulatory T cells via enhancement of oxidative phosphorylation","volume":"365","author":"Chen","year":"2021","journal-title":"Cell. Immunol."}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295225003521?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295225003521?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,16]],"date-time":"2025-07-16T07:03:13Z","timestamp":1752649393000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006295225003521"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":109,"alternative-id":["S0006295225003521"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2025.117087","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Regulatory T cells and their role in inflammatory bowel disease: molecular targets, therapeutic strategies and translational advances","name":"articletitle","label":"Article Title"},{"value":"Biochemical Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcp.2025.117087","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"117087"}}